Enanta Pharmaceuticals Aktie
6,20
EUR
±0,00
EUR
±0,00
%
7,41
USD
+0,08
USD
+1,02
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG |
Werbung
Werbung